<?xml version="1.0" encoding="UTF-8"?>
<document id="29684080">
	<sentence id="s1" text="Patients with heritable cancer syndromes characterized by germline PTEN mutations (termed PTEN hamartoma tumor syndrome, PHTS) benefit from PTEN-enabled cancer risk assessment and clinical management.">
		<entity id="s1.e1" charOffset="24-30"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<entity id="s1.e2" charOffset="67-71"
			type="GENE" text="PTEN" ontology_id="5728"/>
		<entity id="s1.e3" charOffset="105-110"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e2" pgr="true"/>
		<pair id="s1.p2" e1="s1.e2"
		    e2="s1.e3" pgr="true"/>
	</sentence>
	<sentence id="s2" text="PTEN-wildtype patients (~50%) remain at increased risk of developing certain cancers.">
		<entity id="s2.e1" charOffset="0-4"
			type="GENE" text="PTEN" ontology_id="5728"/>
		<entity id="s2.e2" charOffset="77-83"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e2" pgr="true"/>
	</sentence>
	<sentence id="s3" text="Pathogenic or likely pathogenic cancer susceptibility gene alterations were found in 7 of the 87 (8%) CS/CS-like and BRRS patients and included MUTYH, RET, TSC2, BRCA1, BRCA2, ERCC2 and HRAS.">
		<entity id="s3.e1" charOffset="32-38"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<entity id="s3.e2" charOffset="102-104"
			type="GENE" text="CS" ontology_id="1431"/>
		<entity id="s3.e3" charOffset="144-149"
			type="GENE" text="MUTYH" ontology_id="4595"/>
		<entity id="s3.e4" charOffset="151-154"
			type="GENE" text="RET" ontology_id="5979"/>
		<entity id="s3.e5" charOffset="156-160"
			type="GENE" text="TSC2" ontology_id="7249"/>
		<entity id="s3.e6" charOffset="162-167"
			type="GENE" text="BRCA1" ontology_id="672"/>
		<entity id="s3.e7" charOffset="169-174"
			type="GENE" text="BRCA2" ontology_id="675"/>
		<entity id="s3.e8" charOffset="176-181"
			type="GENE" text="ERCC2" ontology_id="2068"/>
		<entity id="s3.e9" charOffset="186-190"
			type="GENE" text="HRAS" ontology_id="3265"/>
		<pair id="s3.p1" e1="s3.e1"
		    e2="s3.e2" pgr="false"/>
		<pair id="s3.p2" e1="s3.e1"
		    e2="s3.e3" pgr="true"/>
		<pair id="s3.p3" e1="s3.e1"
		    e2="s3.e4" pgr="true"/>
		<pair id="s3.p4" e1="s3.e1"
		    e2="s3.e5" pgr="true"/>
		<pair id="s3.p5" e1="s3.e1"
		    e2="s3.e6" pgr="true"/>
		<pair id="s3.p6" e1="s3.e1"
		    e2="s3.e7" pgr="true"/>
		<pair id="s3.p7" e1="s3.e1"
		    e2="s3.e8" pgr="true"/>
		<pair id="s3.p8" e1="s3.e1"
		    e2="s3.e9" pgr="true"/>
	</sentence>
	<sentence id="s4" text="Our data suggest that only a small subset of PTEN-wildtype CS/CS-like and BRRS patients could be accounted for by germline variants in some of the known cancer-related genes.">
		<entity id="s4.e1" charOffset="45-49"
			type="GENE" text="PTEN" ontology_id="5728"/>
		<entity id="s4.e2" charOffset="59-61"
			type="GENE" text="CS" ontology_id="1431"/>
		<entity id="s4.e3" charOffset="153-159"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s4.p1" e1="s4.e1"
		    e2="s4.e3" pgr="true"/>
		<pair id="s4.p2" e1="s4.e2"
		    e2="s4.e3" pgr="false"/>
	</sentence>
</document>
